Skip to main content
. Author manuscript; available in PMC: 2012 Nov 1.
Published in final edited form as: J Am Coll Surg. 2011 Aug 25;213(5):596–603.e1. doi: 10.1016/j.jamcollsurg.2011.07.015

Figure 2.

Figure 2

90-d composite adverse events (CAE) overall (black bars) and dependent upon receipt (blue bars) or non-receipt (red bars) of venous thromboembolism (VTE) pharmacologic prophylaxis shown by hospitals who use pharmacologic prophylaxis most frequently (highest tertile) to least frequently (lowest tertile). *p Value = 0.05 in comparing overall 90-d composite adverse event rates at the hospitals with highest VTE pharmacologic prophylaxis use practices vs lowest use tertile hospitals (2.3% vs 3.6%).